Free Trial
→ JD Vance Predicts: Wall Street vs. Trump & Your Money (From Priority Gold) (Ad)

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 15 of 15

Slide 15
Back to 14
Next Slideshow
 
Back to 14
Next Slideshow
 

Smith & Nephew (NYSE:SNN)

Consensus Rating
Hold
Rating Score
2.3
Ratings Breakdown
1 Buy Ratings, 3 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
N/A

About Smith & Nephew

Smith & Nephew logoSmith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
11/6/2024Berenberg BankDowngradeBuy ➝ Hold
11/1/2024Deutsche Bank AktiengesellschaftDowngradeBuy ➝ Hold
7/24/2024Deutsche Bank AktiengesellschaftInitiated CoverageBuy
6/5/2024UBS GroupUpgradeNeutral ➝ Buy
11/28/2023BarclaysUpgradeUnderweight ➝ Equal Weight
11/3/2023JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight
10/31/2023HSBCUpgradeHold ➝ Buy
10/13/2023Stifel NicolausInitiated CoverageHold
8/8/2023UBS GroupUpgradeSell ➝ Neutral
4/27/2023HSBCDowngradeBuy ➝ Hold

More Investing Slideshows:

Slide 15
Back to 14
Next Slideshow
 

Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)

Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too?

Click Here For Your Free Guide

More From MarketBeat
Bill Gates’ is about to mint millionaires (again) with Stargate.
This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...
Brownstone Research | Sponsored
7 Attractive Dividend Stocks Under $50
As we head into the home stretch of 2024, the playbook for growth investors is the same as one year ago. You'r...
MarketBeat
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
10 Best Penny Stocks to Buy Now
Let's talk penny stocks. We've all played with them at one time or another, buying shares of a company trading...
MarketBeat
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
The Top-Rated Dividend Stocks for 2023
MarketBeat tracks approximately 250,000 analyst recommendations each year and tracks more than 15,000 securiti...
MarketBeat